Company intelligence / Profile preview

PFICUS DE MED

Bangalore, Karnataka, India

Ownership: Private
Employees: ~26
Development stage: Other

Overview

Pficus De Med is an Indian pharmaceutical company based in Bangalore, Karnataka. Founded in 2016, the company focuses on marketing and distributing a range of cardiovascular and metabolic therapies. Its product portfolio includes brands such as Avicus (atorvastatin) and Rosucus (rosuvastatin) for hypercholesterolemia, Telicus (telmisartan) and Benipres (benidipine) for hypertension, and Evog (voglibose) for type 2 diabetes. Pficus De Med operates with WHO GMP-compliant and ISO 9001:2008 accredited manufacturing facilities to deliver high-quality, affordable healthcare solutions.

Therapeutic areas: CardiovascularEndocrinology
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on PFICUS DE MED.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PFICUS DE MED.

Explore the full profile